Cefepime/Sulbactam — A New Innovative Antibiotic for In-Hospital Treatment of Severe Infections and the Implementation of Carbapenem-Replacement Strategy to Contain Antibiotic Resistance

Cefepime/sulbactam is a combined antibiotic consisting of the 4 th generation cephalosporin cefepime and the beta-lactamase inhibitor sulbactam in 1:1 ratio. Cefepime/sulbactam antibiotic was developed in Russia in 2006, it had passed preclinical and clinical studies, was approved for medical use, a...

Full description

Saved in:
Bibliographic Details
Main Authors: S. V. Yakovlev, M. P. Suvorova, A. O. Bykov
Format: Article
Language:Russian
Published: LLC "Publishing House OKI" 2021-06-01
Series:Антибиотики и Химиотерапия
Subjects:
Online Access:https://www.antibiotics-chemotherapy.ru/jour/article/view/807
Tags: Add Tag
No Tags, Be the first to tag this record!